GPR35
From Wikipedia, the free encyclopedia
| G protein-coupled receptor 35 | ||||||||
|---|---|---|---|---|---|---|---|---|
| Identifiers | ||||||||
| Symbol | GPR35 | |||||||
| External IDs | OMIM: 602646 MGI: 1929509 HomoloGene: 3874 IUPHAR: 102 ChEMBL: 1293267 GeneCards: GPR35 Gene | |||||||
|
||||||||
| RNA expression pattern | ||||||||
 |
||||||||
| More reference expression data | ||||||||
| Orthologs | ||||||||
| Species | Human | Mouse | ||||||
| Entrez | 2859 | 64095 | ||||||
| Ensembl | ENSG00000178623 | ENSMUSG00000026271 | ||||||
| UniProt | Q9HC97 | Q9ES90 | ||||||
| RefSeq (mRNA) | NM_001195381 | NM_001104529 | ||||||
| RefSeq (protein) | NP_001182310 | NP_001097999 | ||||||
| Location (UCSC) | Chr 2: 240.61 – 240.63 Mb |
Chr 1: 92.95 – 92.99 Mb |
||||||
| PubMed search | [1] | [2] | ||||||
G protein-coupled receptor 35 also known as GPR35 is a G protein-coupled receptor which in humans is encoded by the GPR35 gene.[1] Heightened expression of GPR35 is found in immune and gastrointestinal tissues, including the crypts of Lieberkühn.
Ligands[edit]
Agonists[edit]
Selective agonists of GPR35 include:
- 5-nitro-2-(3-phenylpropylamino) benzoic acid[2]
- Kynurenic acid[2][3]
- Lysophosphatidic acid[2]
- Pamoic acid[2]
- Zaprinast[2][4]
Antagonists[edit]
Antagonists of GPR35 include:
Clinical significance[edit]
Deletion of GPR35 gene may be responsible for brachydactyly mental retardation syndrome and is mutated in 2q37 monosomy and 2q37 deletion syndrome.[6] In one study GPR35 has been recognised as a potential oncogene in stomach cancer.[7]
References[edit]
- ^ O'Dowd BF, Nguyen T, Marchese A, Cheng R, Lynch KR, Heng HH, Kolakowski LF, George SR (1998). "Discovery of three novel G-protein-coupled receptor genes". Genomics 47 (2): 310–3. doi:10.1006/geno.1998.5095. PMID 9479505.
- ^ a b c d e Zhao, Pingwei; Sharir, Haleli; Kapur, Ankur; Cowan, Alan; Geller, Ellen B; Adler, Martin W; Seltzman, Herbert H; Reggio, Patricia H; Heynen-Genel, Susanne; Sauer, Michelle; Chung, Thomas D Y; Bai, Yushi; Chen, Wei; Caron, Marc G; Barak, Larry S; Abood, Mary E; (2010). "Targeting of the orphan receptor GPR35 by pamoic acid: a potent activator of extracellular signal-regulated kinase and β-arrestin2 with antinociceptive activity.". Molecular Pharmacology 78 (4): 560–568. doi:10.1124/mol.110.066746. PMC 2981393. PMID 20826425.
- ^ Wang J, Simonavicius N, Wu X, Swaminath G, Reagan J, Tian H, Ling L (2006). "Kynurenic acid as a ligand for orphan G protein-coupled receptor GPR35". J. Biol. Chem. 281 (31): 22021–8. doi:10.1074/jbc.M603503200. PMID 16754668.free fulltext
- ^ Taniguchi Y, Tonai-Kachi H, Shinjo K (2006). "Zaprinast, a well-known cyclic guanosine monophosphate-specific phosphodiesterase inhibitor, is an agonist for GPR35". FEBS Lett. 580 (21): 5003–8. doi:10.1016/j.febslet.2006.08.015. PMID 16934253.
- ^ a b Susanne Heynen-Genel, Russell Dahl, Shenghua Shi, Michelle Sauer, Santosh Hariharan, Eduard Sergienko, Shakeela Dad, Thomas DY Chung, Derek Stonich, Ying Su, Marc Caron, Pingwei Zhao, Mary E Abood, and Lawrence S Barak (2010). "Selective GPR35 Antagonists - Probes 1 & 2". PMID 21433393. Bookshelf ID NBK50703.
- ^ Shrimpton AE, Braddock BR, Thomson LL, Stein CK, Hoo JJ (2004). "Molecular delineation of deletions on 2q37.3 in three cases with an Albright hereditary osteodystrophy-like phenotype". Clin. Genet. 66 (6): 537–44. doi:10.1111/j.1399-0004.2004.00363.x. PMID 15521982.
- ^ Okumura S, Baba H, Kumada T, Nanmoku K, Nakajima H, Nakane Y, Hioki K, Ikenaka K (2004). "Cloning of a G-protein-coupled receptor that shows an activity to transform NIH3T3 cells and is expressed in gastric cancer cells". Cancer Sci. 95 (2): 131–5. doi:10.1111/j.1349-7006.2004.tb03193.x. PMID 14965362.
 |
This transmembrane receptor-related article is a stub. You can help Wikipedia by expanding it. |
